- Title: Subtitle
- POSTER: AML-521 The Randomized Phase III SIERRA (Study of Iomab-B in Elderly Relapsed or Refractory AML) Trial: Successful Allogeneic Hematopoietic Stem Cell Transplantation Using Treatment With Iomab-B-Led Regimen for Patients With Active, Relapsed or Refractory AML With Failed Targeted Therapies
- Creators
- Rajneesh NathStuart SeropianHannah ChoeMark R. LitzowCamille AbboudNebu KoshyPatrick J. StiffBenjamin TomlinsonSunil AbhyankarJames M. ForanParameswaran HariGeorge L. ChenZaid S. Al-KadhimiPartow KebriaeiMitchell SabloffJohnnie J. OrozcoKatarzyna JamiesonMargarida Magalhaes-SilvermanKoen Van BesienMichael SchusterArjun LawSameem AbedinKarilyn LarkinScott RowleyPashna MunshiRachel CookSebastian MayerMoshe Yair LevyHillard M. LazarusBrenda M. SandmaierVijay ReddyJennifer SprossKathleen McNamaraElaina HaeuberMadhuri VusirikalaAkash NaharJohn M. PagelSergio A. GiraltAvinash DesaiBoglarka Gyurkocza
- Resource Type
- Abstract
- Publication Details
- Clinical lymphoma, myeloma and leukemia, Vol.23(Suppl. 1), pp.S167-S167
- Publisher
- Elsevier Inc
- DOI
- 10.1016/S2152-2650(23)00485-8
- ISSN
- 2152-2650
- eISSN
- 2152-2669
- Language
- English
- Date published
- 09/2023
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984461349502771
Abstract
POSTER: AML-521 The Randomized Phase III SIERRA (Study of Iomab-B in Elderly Relapsed or Refractory AML) Trial: Successful Allogeneic Hematopoietic Stem Cell Transplantation Using Treatment With Iomab-B-Led Regimen for Patients With Active, Relapsed or Refractory AML With Failed Targeted Therapies
Clinical lymphoma, myeloma and leukemia, Vol.23(Suppl. 1), pp.S167-S167
09/2023
DOI: 10.1016/S2152-2650(23)00485-8
Details
Metrics
3 Record Views